| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10919682 | Radiotherapy and Oncology | 2011 | 8 Pages |
Abstract
Gefitinib was well-tolerated, but did not improve efficacy compared with placebo when given concomitantly with chemoradiotherapy, or as maintenance therapy alone.
Keywords
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Vincent Gregoire, Marc Hamoir, Changhu Chen, Madeleine Kane, Andrzej Kawecki, Pramod K. Julka, Hung-Ming Wang, Srihari Prasad, Anil K. D'Cruz, Ljiljana Radosevic-Jelic, Rejnish R. Kumar, Stanislaw Korzeniowski, Jacek Fijuth, Jean-Pascal Machiels,